Hypertriglyceridemia Medications
Drugs associated with Hypertriglyceridemia
The following drugs and medications are in some way related to, or used in the treatment of Hypertriglyceridemia.
This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
Hypertriglyceridemia Medications in the Pipeline
MK-0524A (niacin ER and laropiprant)
- June 20, 2008
Merck Provides Update on U.S. Regulatory Status of MK-0524A (ER niacin/laropiprant) and MK-0524B (ER niacin/laropiprant/simvastatin) - April 29, 2008
Merck Receives Not Approvable Letter from FDA for MK-0524A (ER niacin/laropiprant) - August 29, 2007
Merck Announces FDA Acceptance of NDA for Cordaptive (ER niacin/laropiprant), Formerly Known as MK-0524A, an Investigational Lipid-Modifier





